Living Health Technology Assessment: Issues, Challenges and Opportunities

Praveen Thokala (), Tushar Srivastava, Robert Smith, Shijie Ren, Melanie D. Whittington, Jamie Elvidge, Ruth Wong and Lesley Uttley
Additional contact information
Praveen Thokala: The University of Sheffield
Tushar Srivastava: The University of Sheffield
Robert Smith: The University of Sheffield
Shijie Ren: The University of Sheffield
Melanie D. Whittington: Institute for Clinical and Economic Review
Jamie Elvidge: National Institute for Health and Care Excellence
Ruth Wong: The University of Sheffield
Lesley Uttley: The University of Sheffield

PharmacoEconomics, 2023, vol. 41, issue 3, No 1, 227-237

Abstract: Abstract Health technology assessments (HTAs) are typically performed as one-off evaluations and can potentially become out-of-date due to the availability of new data, new comparators, or other factors. Recently, living approaches have been applied to systematic reviews and network meta-analyses to enable evidence syntheses to be updated more easily. In this paper, we provide a definition for ‘Living HTA’ where such a living approach could be applied to the entire HTA process. Living HTA could involve performing regular or scheduled updates using a traditional manual approach, or indeed in a semi-automated manner leveraging recent technological innovations that automate parts of the HTA process. The practical implementation of living HTA using both approaches (i.e., manual approach and using semi-automation) is described along with the likely issues and challenges with planning and implementing a living HTA process. The time, resources and additional considerations outlined may prohibit living HTA from becoming the norm for every evaluation; however, scenarios where living HTA would be particularly beneficial are discussed.

Date: 2023
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-022-01229-4 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:41:y:2023:i:3:d:10.1007_s40273-022-01229-4

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-022-01229-4

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().